High-risk genomic alterations in CLL, including TP53 aberrations, NOTCH1 mutations, complex karyotype, and unmutated IGHV, are consistently associated with increased RT risk [10,11,12,13,14,15,16,17]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.